Sustainable Development Goals

Debate between Baroness Blackwood of North Oxford and Baroness Sugg

Thursday 12th November 2020 Lords Chamber

[Baroness Blackwood of North Oxford (Con) [V]]

My Lords, thanks largely to global efforts and UK leadership, recent research shows that the global burden of disease on women has shifted significantly from maternal mortality and morbidity to non-communicable diseases. In particular, the statistics on mental health are distressing. Depression is predicted to be the second-leading cause of global disability by 2020 and it is twice as common and more persistent in women. Dementia is also twice as common in women globally. Women and children are by far the most affected by violence and disaster, with post-traumatic and neurodevelopmental disorders still widely underdiagnosed. Despite all this, mental health accounts for less than 3% of global health budgets. In order to meet SDGs 3 and 5, can the Minister say how much ODA spending will go to women’s NCDs and mental health budgets, in particular?

[Baroness Sugg (Con) [V]]

I agree with my noble friend that mental health is a major concern that affects women around the world. This summer we published our approach paper on mental health and psychosocial disabilities. It clearly outlines our ambition to achieve an integrated and comprehensive rights-based approach to mental health support. It noted the significant gender disparity. It is important that while we continue to support our work on ending preventable deaths, we also address the growing burden of non-communicable diseases.

Covid-19: Access to Vaccine

Debate between Baroness Blackwood of North Oxford and Baroness Sugg

Thursday 15th October 2020 Lords Chamber

[Baroness Sugg (Con)]

My Lords, our commitment to global access to Covid-19 medical tools includes supporting voluntary methods of sharing intellectual property and non-exclusive voluntary licensing agreements. We think it is right to follow both bilateral deals and the COVAX joint facility to maximise the chances of finding a vaccine.

[Baroness Blackwood of North Oxford (Con) [V]]

My Lords, I join other noble Lords in congratulating the Government on joining COVAX and for the significant funding commitment announced at UNGA, but obviously this happened after additional optionality was added to the facility to encourage countries such as the UK, which already have advanced domestic vaccine programmes. Is the Minister confident that vaccine candidates can still be affordably manufactured at scale through COVAX if wealthy countries opt out of certain candidates?